The Curbsiders Internal Medicine Podcast · The Curbsiders Internal Medicine Podcast

#513 Pituitary Incidentalomas

·1 hr 24 min·5 clips

She recommends prolactin and IGF-1 for every pituitary lesion, but not routine Cushing testing.

1. The Curbsiders Internal Medicine Podcast #513 covers pituitary incidentalomas and the workup of a 5-millimeter pituitary lesion. 2. Dr. Matthew Frank Watto, Dr. Paul Nelson-Williams, Dr. Mabeen Ahmad, and guest Dr. Maria Flescheriou shape the discussion, and Flescheriou is the director of the Pituitary Center at Oregon Health and Science University. 3. The episode asks what endocrine testing and imaging follow-up are needed when an MRI for headaches shows a pituitary lesion that was not being sought. 4. Flescheriou defines a pituitary incidentaloma as an incidentally found lesion that can be an adenoma, Rathke cleft cyst, infection, vascular lesion, or another abnormality. 5. She distinguishes microadenoma as less than 10 millimeters, macroadenoma as 10 millimeters or larger, and giant adenoma as more than 4 centimeters. 6. She says lesion size matters, but proximity to the optic chiasm can matter more for vision and pregnancy planning. 7. She notes that better MRI imaging is finding more small lesions, and that some lesions were likely present on older scans but not read at the time. 8. For initial labs, she recommends prolactin and IGF-1 for every pituitary lesion, even when the lesion is small. 9. She says the workup should also look for hypopituitarism with morning cortisol, ACTH, and free T4, because TSH alone can miss central hypothyroidism. 10. She says routine Cushing screening is not recommended in every patient because false positives are common. 11. She explains that symptoms such as obesity, hypertension, diabetes, proximal weakness, or other clinical clues should raise suspicion for Cushing syndrome. 12. She corrects the older phrase “buffalo hump” to “dorsal cervical fat pads” and notes that “moon face” is used less often than “round red face” or “Cushingoid face.” 13. She says a prolactinoma can be treated medically and matters for fertility and other symptoms. 14. She says the newer guidelines removed the old six-millimeter cutoff for closer follow-up because newer data did not support it. 15. She cites a retrospective study of almost 300 patients in which about 10% of microadenomas grew over time. 16. She notes that some cystic lesions can shrink, which is one reason serial imaging still matters. 17. The conversation is practical and teaching-oriented, with Watto asking for definitions and Paul repeatedly translating endocrine concepts into primary care decisions. 18. Flescheriou emphasizes patient communication, including telling patients that most of these lesions are benign and not cancer. 19. People who manage headache workups, incidental imaging findings, or endocrine referrals would get the most from this episode. 20. People looking for a short, nonclinical listen or a purely narrative medical story may skip it.

As heard by us

A brisk, practical endocrine walkthrough on pituitary incidentalomas.

Pituitary incidentalomas are treated as a real clinical problem rather than a curiosity, and the discussion turns that uncertainty into a clear practical map.

Read the full review in PlayNext →

Why you'd press play

Need a clean, bedside-minded way to approach a pituitary incidentaloma?

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Curbsiders Internal Medicine Podcast